ClinicalTrials.govpublic full text
QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC
nsclc, iparomlimab and tuvonralimab, ql1706, checkpoint inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 904389
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.